Welcome to the international HTA database

Showing [16495 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Stiripentol (Diacomit — Biocodex SA) indication: severe myoclonic epilepsy in infancy (Dravet syndrome)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Maxillary artery ligation for the treatment of cluster or migraine headaches: clinical effectiveness and guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Core needle and open surgical biopsy for diagnosis of breast lesions: an update to the 2009 report
2014	University of York	Interventions for loneliness and social isolation
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Clinical review report. Teriflunomide (Aubagio — Genzyme Canada) indication: relapsing-remitting multiple sclerosis
2014	NIHR Health Technology Assessment programme	Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modelling
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hemodialysis chairs versus beds for patients at out-patient clinics: clinical evidence
2014	Belgian Health Care Knowledge Centre (KCE)	A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study
2014	University of York	Self-care support for people with COPD
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pharmacoeconomic review report. Teriflunomide (Aubagio — Genzyme Canada) indication: relapsing-remitting multiple sclerosis
2014	NIHR Horizon Scanning Centre (NIHR HSC)	BreathLink™ for breast cancer screening
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Computed tomography-guided brachytherapy treatment in the operating room: clinical effectiveness, cost-effectiveness, and guidelines
2014	Belgian Health Care Knowledge Centre (KCE)	The long-term efficacy of psychotherapy, alone or in combination with antidepressants, in the treatment of adult major depression.
2014	University of York	Predictive validity of tools used to assess the risk of unplanned admissions: A rapid review of the evidence.
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Teriflunomide (Aubagio — Genzyme Canada) indication: relapsing-remitting multiple sclerosis
2014	NIHR Horizon Scanning Centre (NIHR HSC)	The ViewRay™ System for MRI-guided radiotherapy
2014	Belgian Health Care Knowledge Centre (KCE)	Conceptual framework for the reform of the Belgian hospital payment system
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Guanfacine hydrochloride extended release (Intuniv XR — Shire Canada Inc.) indication: attention deficit hyperactivity disorder
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Ear, nose and throat services - surgical services for obstructive sleep apnoea
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Sheffield Support Snood for neurodegenerative conditions
2014	Belgian Health Care Knowledge Centre (KCE)	Prevention of preterm birth in women at risk: selected topics
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Timothy grass standardized allergenic extract (Grastek — Merck Canada Inc.) indication: allergic rhinitis (grass pollen)
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	MBS reviews paediatric services male circumcision services review report
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Reducer stent for refractory angina
2014	Belgian Health Care Knowledge Centre (KCE)	Oral cavity cancer: diagnosis, treatment and follow-up
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fluticasone furoate /vilanterol (Breo Ellipta — GlaxoSmithKline) indication: chronic obstructive pulmonary disease
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Gastrointestinal liner ('EndoBarrier') to treat diabetes and obesity
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Wireless Cardiac Stimulation System for chronic heart failure
2014	Belgian Health Care Knowledge Centre (KCE)	National practice guideline on the treatment of localised prostate cancer – part 2
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dolutegravir (Tivicay — ViiV Healthcare ULC) indication: HIV infection
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Single dose stereotactic radiosurgery for benign or malignant intracranial tumours (Gamma Knife)
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Nanostim Leadless Pacemaker for atrial fibrillation and bradycardia
2014	Belgian Health Care Knowledge Centre (KCE)	Correction of refractive errors of the eye in adults – part 3: organisation and legal framework of extramural surgery centres
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nephrostomy and biliary tube management: a review of the clinical evidence and guidelines
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Ultrasound imaging in the practice of anaesthesia
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Micra™ Transcatheter Pacing System for atrial fibrillation and bradycardia
2014	Belgian Health Care Knowledge Centre (KCE)	Support for informal caregivers – an exploratory analysis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Natural sheepskins for the treatment of pressure ulcers: clinical effectiveness, cost-effectiveness, and guidelines
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Strokefinder MD100 microwave tomography for early diagnosis of stroke type
2014	Belgian Health Care Knowledge Centre (KCE)	The non-invasive prenatal test (NIPT) for trisomy 21 – health economic aspects
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Regular health monitoring for older adults: clinical evidence
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Lyrette™ for stress urinary incontinence
2014	Belgian Health Care Knowledge Centre (KCE)	Revascularization for lower limb peripheral arterial disease
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Golimumab (Simponi IV — Janssen Inc.) indication: rheumatoid arthritis
2014	Health Technology and Policy Unit (HTPU)	Assisted reproductive technologies (ARTs)
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Mitralign percutaneous annuloplasty system for functional mitral regurgitation
2014	Belgian Health Care Knowledge Centre (KCE)	A decision aid for an informed choice when patient asks for PSA screening
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Riociguat (Adempas — Bayer HealthCare) indication: chronic thromboembolic pulmonary hypertension
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Non-marker based circulating tumour cell capture for solid malignant tumours
2014	Belgian Health Care Knowledge Centre (KCE)	Oncogenetic testing for Lynch syndrome and familial adenomatous polyposis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Use of azathioprine in adults: safety
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Corus® CAD for obstructive coronary artery disease
2014	Belgian Health Care Knowledge Centre (KCE)	Organisation of care for adults with a rare or complex cancer
2014	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Innovative medical devices for diabetes management - Update of Short report n. 6/2012
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Negative pressure wound therapy for managing diabetic foot ulcers: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014	Medical Services Advisory Committee (MSAC)	Cone beam computer tomography (CBCT) for dental/craniofacial imaging
2014	NIHR Horizon Scanning Centre (NIHR HSC)	RAPIDEC® CARBA NP test for confirmation or detection of Carbapenemase producing bacteria
2014	Belgian Health Care Knowledge Centre (KCE)	Colon cancer: diagnosis, treatment and follow-up
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Virtual reality exposure therapy for adults with post-traumatic stress disorder: a review of the clinical effectiveness
2014	Medical Services Advisory Committee (MSAC)	Oncotype DX® breast cancer assay to quantify the risk of disease recurrence and predict adjuvant hemotherapy benefit
2014	NIHR Horizon Scanning Centre (NIHR HSC)	AeriSeal® System for advanced emphysema
2014	Belgian Health Care Knowledge Centre (KCE)	Machine perfusion in kidneys from deceased donors – a rapid assessment – synthesis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hyperbaric oxygen therapy for adults with mental illness: a review of the clinical effectiveness
2014	Medical Services Advisory Committee (MSAC)	National Cervical Screening Program renewal
2014	Belgian Health Care Knowledge Centre (KCE)	Informed choice on breast cancer screening: messages to support informed decision
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Normothermia versus therapeutic hypothermia for adult patients after cardiac arrest: clinical evidence
2014	Medical Services Advisory Committee (MSAC)	Radium 223 for the treatment of patients with symptomatic castrate resistant prostate cancer with skeletal metastases
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Growth measurement of infants and children: guidelines
2014	Medical Services Advisory Committee (MSAC)	HbA1c test for the diagnosis of diabetes mellitus
2014	NIHR Health Services and Delivery Research programme	Rethinking resistance to 'big IT': a sociological study of why and when healthcare staff do not use nationally mandated information and communication technologies
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Neurofeedback and biofeedback for mood and anxiety disorders: a review of the clinical evidence and guidelines
2014	Medical Services Advisory Committee (MSAC)	Catheter-free ambulatory pH test for Gastroesophageal Reflux Disease (GORD)
2014	NIHR Health Technology Assessment programme	The clinical and cost-effectiveness of lenalidomide for people who have received at least one prior therapy with bortezomib (partial review of TA171)
2014	NIHR Health Services and Delivery Research programme	Can valid and practical risk-prediction or casemix adjustment models, including adjustment for comorbidity, be generated from English hospital administrative data (Hospital Episode Statistics)? A national observational study
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Admission of patients with suspected or active infection to oncology units: clinical evidence and guidelines
2014	Medical Services Advisory Committee (MSAC)	Remote monitoring of patients with implanted cardiac devices
2014	NIHR Health Technology Assessment programme	Ipilimumab for previously untreated unresectable malignant melanoma: a single technology appraisal
2014	NIHR Health Services and Delivery Research programme	The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST).
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Breast reduction surgery for hypermastia: clinical effectiveness and guidelines
2014	Medical Services Advisory Committee (MSAC)	The reduction of mitral regurgitation through tissue approximation using transvenous/transeptal techniques
2014	NIHR Health Services and Delivery Research programme	Geographical and temporal understanding in place of death in England (1984–2010): analysis of trends and associated factors to improve end-of-life care (GUIDE_Care) – primary research
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intravenous ketamine for the treatment of mental health disorders: a review of clinical effectiveness and guidelines
2014	Medical Services Advisory Committee (MSAC)	Magnetic Resonance Imaging (MRI) for small bowel and pelvis in Crohn disease
2014	NIHR Health Services and Delivery Research programme	What evidence is there for a relationship between organisational features and patient outcomes in congenital heart disease services? A rapid review
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Endovascular thermal ablation technologies for treatment of varicose veins: a review of clinical effectiveness, safety, cost-effectiveness and guidelines
2014	Medical Services Advisory Committee (MSAC)	Intensive Care Medicine consultation items
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Azacitidine (Vidaza) for acute myeloid leukaemia – first line
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Wear compliance and donning/doffing of respiratory protection for bioaerosols or infectious agents: a review of the effectiveness, safety, and guidelines
2014	Medical Services Advisory Committee (MSAC)	Palliative care consultation items
2014	National Institute for Health and Care Excellence (NICE)	Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers. NICE medical technologies guidance 20
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Ecorafenib and binimetinib for BRAF V600 mutation-positive melanoma – first and second line
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Respiratory precautions for protection from bioaerosols or infectious agents: a review of the clinical effectiveness and guidelines
2014	Medical Services Advisory Committee (MSAC)	Review of interim funded service: breast Magnetic Resonance Imaging (MRI)
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Ibrutinib (Imbruvica) for newly diagnosed chronic lymphocytic leukaemia – first line
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Motor interventions for autism spectrum disorder in children: clinical effectiveness and guidelines
2014	Medical Services Advisory Committee (MSAC)	IncobotulinumtoxinA (XEOMIN), injection of, for blepharospasm, cervical dystonia (spasmodic torticollis) and post-stroke spasticity of the upper limb
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Niraparib for HER2-negative, germline BRCA mutated, locally advanced or metastatic breast cancer – first or second line
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Acetylsalicylic acid for venous thromboembolism prophylaxis: an update of clinical evidence
2014	Medical Services Advisory Committee (MSAC)	RAS (Kirsten RAS and Neuroblastoma RAS) mutation testing for eligibility for panitumumab treatment in previously untreated metastatic colorectal cancer patients.
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Cositecan (Karenitecin) for advanced mucinous epithelial ovarian cancer – second line